Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 36 (Search time: 0.03 seconds).
Issue DateTitleAuthor(s)
2021KRAS MUTATIONS IN PATIENTS WITH NONSQUAMOUS NON-SMALL-CELL LUNG CANCER: PREVALENCE AND RELATIONSHIP WITH PD-L1 EXPRESSION, TUMOR MUTATION BURDEN AND SMOKING STATUSGARASSINO, Marina Chiara; RODRIGUEZ-ABREU, Delvys; GADGEEL, Shirish M.; KOWALSKI, Dariusz M.; KASAHARA, Kazuo; FELIP, Enriqueta; WU, Yi-Long; CASTRO, Gilberto de; CHO, Byoung Chul; TURNA, Hande Z.; HORINOUCHI, Hidehito; RECK, Martin; HUI, Rina; GARON, Edward B.; BOYER, Michael; MOK, Tony S. K.; LOPES, Gilberto; KOBIE, Julie; LI, Yongjin; AYERS, Mark A.; CRISTESCU, Razvan; ZHAO, Bin; PIETANZA, M. Catherine; HERBST, Roy S.
2021KEYNOTE-042 5-YEAR SURVIVAL UPDATE: PEMBROLIZUMAB VERSUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, PD-L1POSITIVE, LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCERCASTRO, Gilberto de; KUDABA, Iveta; WU, Yi-Long; LOPES, Gilberto; KOWALSKI, Dariusz M.; TURNA, Hande Z.; CAGLEVIC, Christian; ZHANG, Li; KARASZEWSKA, Boguslawa; LAKTIONOV, Konstantin K.; SRIMUNINNIMIT, Vichien; BONDARENKO, Igor; KUBOTA, Kaoru; MUKHERJEE, Rinee; LIN, Jianxin; SOUZA, Fabricio; MOK, Tony S. K.; CHO, Byoung Chul
2021PHASE 3 STUDY OF FIRST-LINE PEMBROLIZUMAB WITH AND WITHOUT VIBOSTOLIMAB (ANTI-TIGIT) IN PATIENTS WITH PD-L1-POSITIVE METASTATIC NSCLCHELLMANN, Matthew; CHO, Byoung; JUERGENS, Rosalyn; CHENG, Ying; CASTRO, Gilberto de; ERMAN, Mustafa; BAUMAN, Jessica; TAKAHASHI, Toshiaki; SCHWARZENBERGER, Paul; ZHANG, Pingye; PIETANZA, M. Catherine; YANG, James Chih-Hsin
2021National prevalence of oral HPV infection in vaccinated and unvaccinated young adults in BrazilKOPS, Natalia Luiza; COMERLATO, Juliana; BANDEIRA, Isabel; BESSEL, Marina; MARANHAO, Ana Goretti Kalume; VILLA, Luisa Lina; MOTA, Giana; SOUZA, Flavia Moreno Alves de; PEREIRA, Gerson Fernando Mendes; WENDLAND, Eliana
2021High-accuracy breast cancer detection in mammography using EfficientNet and end-to-end training.PETRINI, Daniel G.; SHIMIZU, Carlos; VALENTE, Gabriel V.; FOLGUEIRA, Guilherme; NOVAES, Guilherme A.; KATAYAMA, Maria L.; SERIO, Pedro; ROELA, Rosimeire A.; TUCUNDUVA, Tatiana C.; FOLGUEIRA, Maria Aparecida A.; KIM, Hae Y.
2021End-to-end training of convolutional network for breast cancer detection in two-view mammography.PETRINI, Daniel G.; SHIMIZU, Carlos; VALENTE, Gabriel V.; FOLGUEIRA, Guilherme; NOVAES, Guilherme A.; KATAYAMA, Maria L.; SERIO, Pedro; ROELA, Rosimeire A.; TUCUNDUVA, Tatiana C.; FOLGUEIRA, Maria Aparecida A.; KIM, Hae Y.
2021First-line (1L) maintenance therapy with niraparib (nira) plus pembrolizumab (pembro) vs placebo plus pembro in advanced/metastatic non-small cell lung cancer (NSCLC): Phase III ZEAL-1L studyRAMALINGAM, S. S.; CASTRO JR., G. de; GARASSINO, M. C. C.; MAZIERES, J.; SANBORN, R. E.; SMIT, E. F. F.; SPIGEL, D. R.; THOMAS, M.; VELCHETI, V.; ZHI, E.; NEIBAUER, M. Whipple; STOJADINOVIC, A.; PETERS, S.
2021STK11 and KEAP1 mutational status and their impact in survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors: Meta-analyses of clinical trials and cohort studiesCASTRO JR., G. de; KASHIURA, D.; HARADA, G.; TORRES, L. Lima; CODIMA, A.; MONTEIRO, G.; COSTA, I. G.; JULIAN, G. S.
2021Relationship between p16 and tumor-infiltrating lymphocytes in Peruvian patients with head and neck cancerCASTANEDA, C. A.; GARCIA, M. Castillo; BERNABE, L. A.; SANCHEZ, J.; TELLO, K.; ALATRSITA, R.; VILLA, L.; SICHERO, L.; ENCISO, J.; GUERRA, H.
2021Stage-dependent prognostic value of systemic inflammatory biomarkers in early triple-negative breast cancer (TNBC)MARTA, G. Nader; TIECHER, R. Dahmer; VICENTINI, M. F. Batistuzzo; DORNELLAS, A.; HOFF, P. M.; TESTA, L.